LT Medical: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
LT Medical
Largest movements
- Cash +€55,550
up €55,550 (+16946.3%), from €328 to €55,878
mainly Net result for the year (+€62,179) and Deferred charges and accrued income (+€12,766)
- Tangible fixed assets +€19,375
new in 2025: €19,375
- Deferred charges and accrued income -€12,766
no longer reported in 2025 (was €12,766)
- Receivables after one year +€8,000
new in 2025: €8,000
- Profit (loss) carried forward +€62,179
up €62,179 (+925.9%), from €6,715 to €68,895
- Tax, wage and social debts +€9,900
up €9,900 (+521.1%), from €1,900 to €11,800
- Other debts -€1,920
down €1,920 (-77.5%), from €2,478 to €558
- Gross operating margin +€70,869
up €70,869 (+791.4%), from €8,955 to €79,825
- Taxes +€15,498
up €15,498 (+815.7%), from €1,900 to €17,398
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €13,093 | €83,253 | +€70,160 | +535.8% |
| Fixed assets | 21/28 | - | €19,375 | +€19,375 | |
| Tangible fixed assets | 22/27 | - | €19,375 | +€19,375 | |
| Other tangible fixed assets | 26 | - | €19,375 | +€19,375 | |
| Current assets | 29/58 | €13,093 | €63,878 | +€50,784 | +387.9% |
| Amounts receivable after more than one year | 29 | - | €8,000 | +€8,000 | |
| Other amounts receivable | 291 | - | €8,000 | +€8,000 | |
| Cash at bank and in hand | 54/58 | €328 | €55,878 | +€55,550 | +16946.3% |
| Deferred charges and accrued income | 490/1 | €12,766 | - | -€12,766 | |
| Total equity and liabilities | 10/49 | €13,093 | €83,253 | +€70,160 | +535.8% |
| Equity | 10/15 | €8,715 | €70,895 | +€62,179 | +713.5% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €6,715 | €68,895 | +€62,179 | +925.9% |
| Amounts payable | 17/49 | €4,378 | €12,358 | +€7,980 | +182.3% |
| Amounts payable within one year | 42/48 | €4,378 | €12,358 | +€7,980 | +182.3% |
| Taxes, remuneration and social security | 45 | €1,900 | €11,800 | +€9,900 | +521.1% |
| Taxes | 450/3 | €1,900 | €11,800 | +€9,900 | +521.1% |
| Other amounts payable | 47/48 | €2,478 | €558 | -€1,920 | -77.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €99 | +€99 | |
| Other operating charges | 640/8 | €340 | €254 | -€86 | -25.4% |
| Gross operating margin | 9900 | €8,955 | €79,825 | +€70,869 | +791.4% |
| Operating profit (loss) | 9901 | €8,615 | €79,472 | +€70,857 | +822.5% |
| Financial income | 75/76B | - | €120 | +€120 | |
| Recurring financial income | 75 | - | €120 | +€120 | |
| Financial charges | 65/66B | - | €15 | +€15 | |
| Recurring financial charges | 65 | - | €15 | +€15 | |
| Profit (loss) for the period before taxes | 9903 | €8,615 | €79,577 | +€70,962 | +823.7% |
| Income taxes | 67/77 | €1,900 | €17,398 | +€15,498 | +815.7% |
| Profit (loss) for the period | 9904 | €6,715 | €62,179 | +€55,464 | +825.9% |
| Profit (loss) for the period to be appropriated | 9905 | €6,715 | €62,179 | +€55,464 | +825.9% |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.